Chronic Wounds Market
Chronic Wounds Market Infographics

Chronic Wounds Overview

Chronic wounds are characterized as those that cannot heal in the expected amount of time. They are frequently abused and pervasive. When a wound has not entirely healed even after four to six weeks of screening, it is regarded as chronic or non-healing. Examples of typical chronic wound types include venous ulcers (VU [Vein ulcers, arterial ulcers], diabetic foot ulcers (DFU), and pressure ulcers (PU).

Chronic Wounds Epidemiology Insights (2021)

The Total Diagnosed Prevalent Cases of Chronic wounds in the 7MM were 7 million cases (approx)

Chronic Wounds Epidemiology Segmentation in the 7MM from 2019 to 2032

  • Total Diagnosed Prevalent Cases
  • Type-specific Diagnosed Prevalent Cases

Chronic Wounds Market Insight (2021)

The Chronic Wounds Market size in the 7MM was valued ~USD 5,232 million in 2021

Chronic Wounds Emerging Drugs and Companies

  • Adipose Derived Regenerative Cells (ADRCs): Paracrine, Inc.
  • ON101: Oneness Biotech
  • TTAX01: Biotissue
  • SkinTE: PolarityTE
  • EscharEx: MediWound
  • ALLO-ASC-DFU: Anterogen Co., Ltd.
  • TR-987: TR Therapeutics
  • Allo-APZ2: RHEACELL GmbH & Co. KG, and others